Congratulations to Heli Jeskanen, who just won the best poster award related to PMG-AD project in the JPND meeting at Brussels! @UEF_Biomed@UEFNeuroInno@UEFneuroscience
Professori Annakaisa Haapasalo puhuu professuuriesitelmässään aiheesta "Otsalohkodementian translationaalinen tutkimus – molekyylimekanismeista tautibiomarkkereihin ja uusiin hoitoihin".
#professuuriesitelmät#MeOlemmeUEF
Please check our latest findings related to effects of PLCG2 variant on AD pathology @UEFneuroscience@SuomenAkatemia Protective variant in PLCgamma2 mitigates Alzheimer's disease associated pathology via enhancing beneficial microglia functions https://t.co/2Zz3ZmGGSR
Excellent collaboration with Maria Jose Diogenes group! A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease: Molecular Therapy https://t.co/ReK0cLSt8d
Pioneering study identifies six genetic regions associated with normal pressure hydrocephalus. Published in Neurology, the study is the first large-scale genome-wide association study related to NPH in the world. @GreenJournal@UEFneuroscience@KuopioNPH https://t.co/yMJ4N8PKpv
Uraauurtava tutkimus tunnisti kuusi normaalipaineiseen hydrokefaliaan liittyvää geenialuetta. Kyseessä ensimmäinen laajamittainen koko genomin kattava tutkimus NPH-taudista maailmassa. @UEFneuroscience@Pshyvinvointi@HiltunenLab@KuopioNPH@ClinmedUef https://t.co/ZhOL4an3LE
Six novel gene loci identified in normal pressure hydrocephalus! @KuopioNPH@SuomenAkatemia@FinnGen_FI@UEFneuroscience Risk Variants Associated With Normal Pressure Hydrocephalus | Neurology https://t.co/sVcK5LXbJZ
📢Publication of the first study investigating how genetic factors influence changes in neuroimaging markers during a 2-year multidomain lifestyle intervention
Congrats to the authors👏
@drsaadmaan@HiltunenLab@TiiaNgandu@HilkkaSoininen@MiiaKivipelto
https://t.co/bBA8D3zbui
A new preprint from Mikko Hiltunen's group utilises FinnGen to show that the Finnish TYROBP deletion associates with an increased risk and earlier onset of dementia and Alzheimer’s disease in the monoallelic carriers.
The #alzheimersdisease risk gene PLCγ2 acts in neurons as well as microglia, maintaining synapse number and excitability. @PasteurLille https://t.co/HVtJcx9iNX
Great collaboration with Lambert lab - Neuronal downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease hallmarks https://t.co/Qy6zx0juQP
Kansainvälinen @alzassociation myönsi Neurotieteiden tutkimusyhteisön tutkijoille merkittävän rahoituksen hankkeeseen, jossa tutkitaan Alzheimer-riskiin liittyvien TMEM106B-geenimuutosten vaikutusmekanismeja. @UEFneuroscience@HiltunenLab @LabMalm https://t.co/jvp5MrVM5k
"Dementia is not one specific disease, instead it is an overarching term describing a group of diseases characterized by progressive cognitive decline, associated with degeneration of brain matter."
Find out more by reading the post written by our PhD researcher Elena Ppali 🧠